Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05763082 · ClinicalTrials.gov registry record · Phase 3
Bioequivalence Study of Two Treatments for the Treatment of Plaque Psoriasis
A Phase 3 study, sponsored by Padagis.
- Completed
- Registry status
- Phase 3
- Development phase
- 414
- Enrollment target
NCT05763082: Completed Phase 3 study, sponsored by Padagis.
NCT05763082 is a Phase 3 study that has completed, run by Padagis. The registered enrollment target is 414 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (46% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05763082, a Phase 3 study, has completed, sponsored by Padagis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 414 participants
- Enrollment target
Study Summary
To compare the safety and efficacy of Padagis' product to an FDA approved product for the treatment of plaque psoriasis
Primary Outcome
percentage of subjects at Day 56 who achieve Treatment Success, which is defined as an IGA score of None (0) or Minimal (1) with a 2-grade improvement from Day 1
Interventions
- DRUG Placebo
- DRUG roflumilast cream 0.3%
- DRUG Zoryve
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 414 participants |
| Start Date | 2023-02-07 |
| Est. Completion | 2023-08-08 |
| Phase | Phase 3 |
What the finished NCT05763082 record still lists
NCT05763082 is an interventional study that assigns participants to a tested intervention. The registered 414 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (46% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT05763082 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05763082 about?
NCT05763082 is a clinical study titled "Bioequivalence Study of Two Treatments for the Treatment of Plaque Psoriasis". To compare the safety and efficacy of Padagis' product to an FDA approved product for the treatment of plaque psoriasis
What is the current status of trial NCT05763082?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 414 participants. The study started on 2023-02-07. Estimated completion is 2023-08-08.
What interventions are being tested in trial NCT05763082?
The interventions under investigation include: Placebo (DRUG), roflumilast cream 0.3% (DRUG), Zoryve (DRUG).
Who is sponsoring clinical trial NCT05763082?
This trial is sponsored by Padagis, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05763082's enrollment target sits among peer trials
414 905th of 2000 higher than 1,096 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04776941 · 414 participants · NA
Expressive Writing for the Management of Stress in Cancer Survivors
- NCT06792552 · 414 participants · Phase 1
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
- NCT05142605 · 415 participants · NA
Evaluation of Grief Therapy Approaches for Bereaved Parents
- NCT03592472 · 413 participants · Phase 3
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI